Rockefeller Capital Management
PBYI icon

Rockefeller Capital Management’s Puma Biotechnology PBYI Stock Holding History

Rockefeller Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.07K Buy
793
+634
+399% +$4.09K ﹤0.01% 4238
2025
Q4 		$946 Buy
+159
New +$844 ﹤0.01% 4453
2023
Q1 		– Sell
-14
Closed – – 3327
2022
Q4 		$0 Sell
14
-261
-95% -$901 ﹤0.01% 4121
2022
Q3 		$0 Hold
275
– – ﹤0.01% 4258
2022
Q2 		$0 Hold
275
– – ﹤0.01% 4321
2022
Q1 		$0 Hold
275
– – ﹤0.01% 4021
2021
Q4 		$0 Sell
275
-1,048
-79% -$4.55K ﹤0.01% 3937
2021
Q3 		$9K Sell
1,323
-55,779
-98% -$418K ﹤0.01% 2941
2021
Q2 		$524K Buy
+57,102
New +$579K ﹤0.01% 1179
2020
Q4 		– Sell
-157
Closed -$1K – 2975
2020
Q3 		$1K Buy
157
+58
+59% +$591 ﹤0.01% 2519
2020
Q2 		$1K Sell
99
-64
-39% -$662 ﹤0.01% 2485
2020
Q1 		$1K Buy
+163
New +$1.58K ﹤0.01% 2300
2019
Q4 		– Sell
-4,900
Closed -$53K – 2168
2019
Q3 		$53K Buy
4,900
+100
+2% +$1.08K ﹤0.01% 951
2019
Q2 		$61K Hold
4,800
– – ﹤0.01% 782
2019
Q1 		$186K Hold
4,800
– – ﹤0.01% 625
2018
Q4 		$98K Buy
+4,800
New +$144K ﹤0.01% 459

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Rockefeller Capital Management's PBYI Position: Q1 2026 in Review

Rockefeller Capital Management increased its Puma Biotechnology (PBYI) stake by 399% in Q1 2026, buying an estimated $4.09K and bringing the position to 793 shares worth $5.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4238.

Rockefeller Capital Management first reported a position in PBYI in Q4 2018 and has held it in 16 quarters since. The position peaked at $524K in Q2 2021. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Rockefeller Capital Management held 793 shares of Puma Biotechnology worth $5.07K as of Q1 2026.
  • Rockefeller Capital Management bought 634 Puma Biotechnology shares in Q1 2026, an estimated $4.09K.
  • Puma Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4238 holding.
  • Rockefeller Capital Management first reported a position in Puma Biotechnology in Q4 2018 and has held it in 16 quarters since.
  • Rockefeller Capital Management's Puma Biotechnology position peaked at $524K in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.